|By PR Newswire||
|September 2, 2014 01:21 PM EDT||
BALTIMORE, Sept. 2, 2014 /PRNewswire/ -- AmeritoxSM, the nation's leader in medication monitoring solutions, today released, "A Deadly Trend: Prescription Drugs to Heroin," a research report that provides concrete evidence linking prescription drug abuse to heroin abuse, and examines deadly trends that have created a unique heroin epidemic. The full can be found here.
The report is based on data collected from urine drug testing of patients prescribed opioids. It examines five trends that distinguish the heroin abuse currently ravaging communities across the U.S. from the heroin scourges of the past. Among the key findings in the report:
- Frequently, other illicit drugs and prescription drugs are combined with heroin use: 20 percent of heroin-positive samples also tested positive for a non-prescribed sedative hypnotic, such as Xanax or Valium, and 19 percent tested positive for cocaine.
- Bouncing between drugs is common: Patients who tested positive for heroin did not test positive for their prescribed opioid 56 percent of the time.
"Ameritox is committed to preventing the human tragedy that too often results from prescription painkiller and heroin abuse," said CEO Scott Walton. "We hope that this research and report will serve as a resource for clinicians and others who share that goal."
The data in the report was pulled from approximately 170,000 chronic pain patient samples tested by Ameritox for heroin over a two-year period. The research is being presented during the National PAIN Week conference in Las Vegas, Nevada this week.
Members of Ameritox's Medical Affairs team will also present in-depth research with a medical poster entitled, "Heroin Use Among Pain Patients Prescribed Opioids." A second research effort examines prescribing habits to explore trends in morphine equivalent dosing.
Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse, and diversion. As the nation's trusted leader in Pain Medication Monitoring SolutionsSM, Ameritox provides medical and business professionals with health care solutions that can help improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has 800 employees nationwide and laboratory facilities in Greensboro, N.C.
Cloud Expo, Inc. has announced today that Andi Mann returns to 'DevOps at Cloud Expo 2017' as Conference Chair The @DevOpsSummit at Cloud Expo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great t...
Dec. 10, 2016 03:45 PM EST Reads: 867
Rapid innovation, changing business landscapes, and new IT demands force businesses to make changes quickly. In the eyes of many, containers are at the brink of becoming a pervasive technology in enterprise IT to accelerate application delivery. In this presentation, attendees learned about the: The transformation of IT to a DevOps, microservices, and container-based architecture What are containers and how DevOps practices can operate in a container-based environment A demonstration of how ...
Dec. 10, 2016 03:45 PM EST Reads: 1,297
"At ROHA we develop an app called Catcha. It was developed after we spent a year meeting with, talking to, interacting with senior citizens watching them use their smartphones and talking to them about how they use their smartphones so we could get to know their smartphone behavior," explained Dave Woods, Chief Innovation Officer at ROHA, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Dec. 10, 2016 03:30 PM EST Reads: 890
Dec. 10, 2016 02:45 PM EST Reads: 870
Dec. 10, 2016 02:45 PM EST Reads: 1,229
Dec. 10, 2016 02:30 PM EST Reads: 2,043
Dec. 10, 2016 01:45 PM EST Reads: 667
Dec. 10, 2016 01:00 PM EST Reads: 393
Dec. 10, 2016 01:00 PM EST Reads: 1,241
Dec. 10, 2016 12:45 PM EST Reads: 2,137
Dec. 10, 2016 12:30 PM EST Reads: 1,967
Dec. 10, 2016 12:15 PM EST Reads: 7,468
Dec. 10, 2016 12:15 PM EST Reads: 2,284
Dec. 10, 2016 12:00 PM EST Reads: 786
Dec. 10, 2016 12:00 PM EST Reads: 1,097